GW Pharmaceuticals PLC Holding(s) in Company (2256O)
November 03 2016 - 3:47AM
UK Regulatory
TIDMGWP
RNS Number : 2256O
GW Pharmaceuticals PLC
03 November 2016
For filings with the FCA
include the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
------------------------------------------------------------------------------------------------------------
1. Identity of the issuer or GW Pharmaceuticals plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
--------------------------------------------------------------- -------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
--------------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
--------------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
--------------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
--------------------------------------------------------------------------------------------------------
Other (please Change in issuer's total voting rights x
specify):
--------------------------------------------------------- ---------------------------------------------
3. Full name of person(s) The Capital Group Companies,
subject to the Inc.
notification obligation:
(iii)
----------------------------------------------------------- -----------------------------------------------
4. Full name of shareholder(s) See Section 9
(if different from 3.):(iv)
----------------------------------------------------------- -----------------------------------------------
5. Date of the transaction 1 November 2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- -----------------------------------------------
6. Date on which issuer 2 November 2016
notified:
----------------------------------------------------------- -----------------------------------------------
7. Threshold(s) that is/are Below 15% - Aggregate of voting
crossed or rights from shares
reached: (vi, vii)
----------------------------------------------------------- -----------------------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
--------------- --------------------------------- ------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
--------------- --------------- ---------------- -------------- ----------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
--------------- ----------- ------------ -------------- --------- ------------ ------------ -----------
ADRs
(US36197T1034) 3,778,439 45,341,270 45,341,270 14.9909%
--------------- --------------- ---------------- -------------- --------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------- ------------- -------------------------------- ------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
----------------- ------------- -------------- ---------------- ------------------------- -----------------------
Nominal Delta
----------------- ------------- -------------- ---------------- ------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
---------------------------------------------------- ----------------------------------------------------------------
45,341,270 14.9909%
---------------------------------------------------- ----------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------------------------------------
Number of Percent
Shares of Outstanding
The Capital Group Companies, Inc.
("CG") holdings 45,341,270 14.9909%
Holdings by CG Management Companies
and Funds:
------------------------------------------- ----------- ----------------
-- Capital Guardian Trust Company(1)
-- Capital Research and Management
Company(2) 45,340,850 14.9908%
* SMALLCAP World Fund, Inc.(3) 23,716,800 7.8414%
(1) Indirect subsidiaries of Capital Research and Management
Company.
(2) Subsidiary of The Capital Group Companies, Inc.
(3) Mutual fund managed by Capital Research and Management
Company.
-----------------------------------------------------------------------------------------------
Proxy Voting:
-----------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------------------------ ---------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------------------------ ---------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------------------------ ---------------
13. Additional information:
------------------------------------------------------------------------------ ---------------
14. Contact name: Vivien Tan
------------------------------------------------------------------------------ ---------------
15. Contact telephone number: (213) 615-0469
------------------------------------------------------------------------------ ---------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAXFDELDKFEF
(END) Dow Jones Newswires
November 03, 2016 03:47 ET (07:47 GMT)
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Nov 2024 to Dec 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Dec 2023 to Dec 2024
